REFERENCES
- NIOSH Alert: Preventing occupational exposures to antineoplasticand other hazardous drugs in healthcare settings. 2004. U.S. Department ofHealth and Human Services, Public Health Service, Centers for Disease Controland Prevention, National Institute for Occupational Safety and Health, DHHS(NIOSH) Publication No. 2004-165.
- OSHA Technical Manual, TED 1-0.15A, Section VI: Chapter 2. ControllingOccupational Exposure to Hazardous Drugs. OSHA, 1999. http://www.osha.gov/dts/osta/otm/otm_vi/otm_vi_2.html
- American Society of Health-System Pharmacists. ASHP guidelines onhandling hazardous drugs. Am J Health-Syst Pharm. 2006;63:1172-1193.
- Polovich M, White JM, Kelleher LO, eds. 2005. Chemotherapy and biotherapyguidelines and recommendations for practice (2nd ed.) Pittsburgh, PA: OncologyNursing Society.
Bristol-MyersSquibb Company Princeton, NJ 08543 USA Made in Italy 1050973A3 RevJune 2009
|